Added to YB: 2024-12-03
Pitch date: 2024-07-02
PAX.ST [bullish]
Paxman AB (publ)
+25%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide.
Market Cap
SEK 1.4B
Pitch Price
SEK 52.00
Price Target
N/A
Dividend
N/A
Sector
Health Care Equipment and Supplies
Category
value
Show full summary:
Paxman AB: Transforming Scalability and Growth in Scalp Cooling Solutions
PAX.ST: Market leader in scalp cooling for chemo patients. 5,500+ systems, 60+ markets. US expansion driving growth (36% vs competitor's 9%). New Buy/Bill model boosting utilization 100-300%. Conservative est: 76% margin, 2x sales, 10x 2026e EBIT. Risks: low-tech product, chemo alternatives. CIPN research upside.
Read full article (4 min)